Objective: Breast cancer (BC) is a common malignancy among women worldwide. Fibroblast growth factor receptor 2 (FGFR2) rs2981582 is reported to play a vital role in BC development. However, the relationship between them remains unclear.
Methods: Ninety-five patients and 140 healthy controls were enrolled in the study. Plasma DNA was genotyped by the MassARRAY method. A meta-analysis was conducted to clarify the effect of FGFR2 polymorphism on BC risk.
Results: Our case-control study results revealed a significant difference in CC, TC, and TT genotypes between patients and controls. Logistic regression analysis showed that TT and TC genotype and the dominant mode were significantly correlated with BC development [odds ratio (OR) = 1.21, 95% confidence interval (CI): 1.050–2.27; OR = 1.81, 95% CI: 1.24–2.73; OR = 2.15, 95% CI: 1.25–5.31, respectively], even after adjusting for age, body weight, drinking, smoking, and estrogen receptor status. A meta-analysis of 15 studies showed significant differences among the dominant, recessive, heterozygote, and homozygote models between patients and controls.
Conclusions: Our results showed an association of FGFR2 rs2981582 polymorphism with BC in an Asian population. However, a more comprehensive study of the relationship between the polymorphism and BC is still needed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833426 | PMC |
| http://dx.doi.org/10.1177/0300060519869058 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
FGFR2 genetic variants in women with breast cancer.
Mol Med Rep
December 2023
Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of The Witwatersrand, Johannesburg 2193, South Africa.
Black African populations are more genetically diverse than others, but genetic variants have been studied primarily in European populations. The present study examined the association of four single nucleotide polymorphisms (SNPs) of the fibroblast growth factor receptor 2, associated with breast cancer in non‑African populations, with breast cancer in Black, southern African women. Genomic DNA was extracted from whole blood samples of 1,001 patients with breast cancer and 1,006 controls (without breast cancer), and the rs2981582, rs35054928, rs2981578, and rs11200014 polymorphisms were analyzed using allele‑specific Kompetitive allele‑specific PCR™, and the χ or Fisher's exact tests were used to compare the genotype frequencies.
View Article and Find Full Text PDFEvaluation of the Association between Gene Polymorphisms and Breast Cancer Risk in the Bangladeshi Population.
Genes (Basel)
March 2023
Department of Pharmacy, Faculty of Science, Noakhali Science and Technology University, Noakhali 3814, Bangladesh.
Breast cancer is considered the most frequent cause of mortality from malignancy among females. Fibroblast growth factor receptor 2 () gene polymorphisms are highly related to the risk of breast cancer. However, no investigation has been carried out to determine the association of gene polymorphisms in the Bangladeshi population.
View Article and Find Full Text PDFCOL1A1 and FGFR2 Single-Nucleotide Polymorphisms Found in Class II and Class III Skeletal Malocclusions in Javanese Population.
Eur J Dent
February 2023
Department of Informatics, Institute Technology of Sepuluh Nopember, Surabaya, Indonesia.
Objective: The aim of this article is to analyze and compare the presence of single-nucleotide polymorphisms (SNPs) of and in class II and class III Javanese populations.
Materials And Methods: Cephalometric radiographs from total 63 patients of class II and III were analyzed. SNP analysis was performed based on both and sequences amplified from total DNA of patients' fresh blood.
Fibroblast growth factor receptor 2 gene () rs2981582T/C polymorphism and susceptibility to breast cancer in Saudi women.
Saudi J Biol Sci
November 2021
Department of Biology, College of Science, Taibah University, Madinah, Saudi Arabia.
Fibroblast growth factor receptor 2 is a protein encoded by gene and plays an important role in cellular growth. This study was conducted to investigate a potential association of rs2981582 with breast cancer. DNA was obtained from 137 Formalin-fixed, paraffin-embedded tumors and 98 normal breast tissue samples.
View Article and Find Full Text PDFGenetic polymorphism of fibroblast growth factor receptor 2 and trinucleotide repeat-containing 9 influence the susceptibility to HCV-induced hepatocellular carcinoma.
Clin Res Hepatol Gastroenterol
November 2021
Tropical Medicine Department, Faculty of Medicine, Menoufia University, Egypt. Electronic address:
Article Synopsis
- FGFR2 rs2981582 and TNRC9 rs12443621 gene polymorphisms were studied to determine their link to hepatocellular cancer (HCC) risk in patients with HCV.
- Genotyping showed that the FGFR2 TT genotype increased HCC risk compared to controls, but was protective in HCV patients, while certain TNRC9 genotypes significantly raised the HCC risk.
- The findings suggest that these SNPs may play a role in the development of HCC in individuals chronically infected with HCV, with different genotypes associated with tumor size and stage.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!